Skip to content

CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients

CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04675515
Enrollment
2
Registered
2020-12-19
Start date
2021-01-19
Completion date
2024-02-16
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Tobacco Use

Brief summary

The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.

Detailed description

This mixed-methods, observational cohort study will assess intensive tobacco treatment with carbon monoxide monitoring offered to all eligible smoking patients presenting for cancer treatment to the NCCC at our main Lebanon campus and our very rural St. Johnsbury campus. Subjects will not be randomized and study will not be blinded. Cessation rates among the intensive tobacco treatment will be compared to usual care, matched historical controls, and to patients who refuse all tobacco treatment program elements.

Interventions

BEHAVIORALIntensive Tobacco Treatment

Bi-weekly tobacco treatment counseling and regular carbon monoxide monitoring

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults age 18 and older * Active Smoker at the time of initial consultation for cancer (defined as any smoking within 2 weeks of consult)

Exclusion criteria

* Adults unable to consent * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Change is smoking status30 days, 3 Months, 6 MonthsChange in smoking status (from smoking to not smoking) of those in an intensive tobacco treatment program at 30 days, 3 months and 6 months

Secondary

MeasureTime frameDescription
Motivational Impact of real-time carbon monoxide monitoring6 MonthsMotivational impact of real-time carbon monoxide monitoring in patients receiving intensive tobacco treatment as determined by a Motivation to Quit Assessment Questionnaire
Engagement Level with Tobacco Treatment via Telehealth6 MonthsLevel of engagement with tobacco treatment via telehealth compared to historical control face-to-face visits as determined by a Technology Access and Experiences Questionnaire

Other

MeasureTime frameDescription
Engagement Level With Tobacco Treatment for Low Resource Patients outh!6 MonthsLevel of engagement with tobacco treatment for low-resource patients who are provided cell phones with data plans as determined by a Technology Access and Experiences Questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026